Rapid decline of follicular lymphoma-associated chylothorax after low dose radiotherapy to retroperitoneal lymphoma localization.
Lien Van De VoordeBen G L VannesteJacques BorgerEsther G C TroostPhilo WernerPublished in: Case reports in hematology (2014)
Chylothorax is caused by disruption or obstruction of the thoracic duct or its tributaries that results in the leakage of chyle into the pleural space. A number of interventions have been used to treat chylothorax including the treatment of the underlying disease. Lymphoma is found in 70% of cases with nontraumatic malignant aetiology. Although patients usually have advanced lymphoma, supradiaphragmatic disease is not always present. We discuss the case of a 63-year-old woman presenting with progressive respiratory symptoms due to chylothorax. She was diagnosed with a stage IIE retroperitoneal grade 1 follicular lymphoma extending from the coeliac trunk towards the pelvic inlet. Despite thoracocentesis and medium-chain triglycerides (MCT), diet chylothorax reoccurred. After low dose radiotherapy (2 × 2 Gy) to the abdominal lymphoma there was a marked decrease in lymphadenopathy at the coeliac trunk and a complete regression of the pleural fluid. In this case, radiotherapy was shown to be an effective nontoxic treatment option for lymphoma-associated chylothorax with long-term remission of pleural effusion.
Keyphrases
- low dose
- diffuse large b cell lymphoma
- early stage
- radiation therapy
- locally advanced
- physical activity
- end stage renal disease
- radiation induced
- multiple sclerosis
- chronic kidney disease
- high dose
- spinal cord
- ejection fraction
- prognostic factors
- rheumatoid arthritis
- spinal cord injury
- weight loss
- robot assisted
- patient reported outcomes
- disease activity
- high density
- sleep quality